Business Description
SpectraCure AB
ISIN : SE0007158118
Compare
Compare
Traded in other countries / regions
SPEC.Sweden2OK.Germany IPO Date
2015-06-29Description
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.98 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -10.5 | |||||
| 3-Year EPS without NRI Growth Rate | -7.5 | |||||
| 3-Year FCF Growth Rate | -19.9 | |||||
| 3-Year Book Growth Rate | -13 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78.25 | |||||
| 9-Day RSI | 65.06 | |||||
| 14-Day RSI | 60.65 | |||||
| 6-1 Month Momentum % | 37.86 | |||||
| 12-1 Month Momentum % | -17.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.57 | |||||
| Quick Ratio | 2.57 | |||||
| Cash Ratio | 2.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.41 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -18.41 | |||||
| ROA % | -16.39 | |||||
| ROIC % | -25.46 | |||||
| 3-Year ROIIC % | -18.37 | |||||
| ROC (Joel Greenblatt) % | -332.6 | |||||
| ROCE % | -17.45 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.57 | |||||
| Price-to-Tangible-Book | 13.87 | |||||
| EV-to-EBIT | -12.93 | |||||
| EV-to-EBITDA | -14.65 | |||||
| EV-to-FCF | -8.01 | |||||
| Price-to-Net-Current-Asset-Value | 19.94 | |||||
| Price-to-Net-Cash | 24.54 | |||||
| Earnings Yield (Greenblatt) % | -7.74 | |||||
| FCF Yield % | -10.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SpectraCure AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.22 | ||
| Beta | 0 | ||
| Volatility % | 88.58 | ||
| 14-Day RSI | 60.65 | ||
| 14-Day ATR (kr) | 0.492946 | ||
| 20-Day SMA (kr) | 2.886 | ||
| 12-1 Month Momentum % | -17.69 | ||
| 52-Week Range (kr) | 0.829 - 5.11 | ||
| Shares Outstanding (Mil) | 97.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SpectraCure AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SpectraCure AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
SpectraCure AB Frequently Asked Questions
What is SpectraCure AB(OSTO:SPEC)'s stock price today?
The current price of OSTO:SPEC is kr3.19. The 52 week high of OSTO:SPEC is kr5.11 and 52 week low is kr0.83.
When is next earnings date of SpectraCure AB(OSTO:SPEC)?
The next earnings date of SpectraCure AB(OSTO:SPEC) is 2025-02-20.
Does SpectraCure AB(OSTO:SPEC) pay dividends? If so, how much?
SpectraCure AB(OSTO:SPEC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers